WRN Promoter CpG Island Hypermethylation Does Not Predict a Favourable Outcome for Irinotecan-treated Metastatic Colorectal Cancer Patients

被引：0

作者：

Bosch, L. J. W. ^{[1
]}

Luo, Y. ^{[2
]}

Lao, V. V. ^{[3
]}

Snaebjornsson, P. ^{[1
]}

Trooskens, G. ^{[4
]}

Vlassenbroeck, I. ^{[5
]}

Mongera, S. ^{[1
]}

Tang, W. ^{[3
]}

Welcsh, P. ^{[3
]}

Herman, J. ^{[6
]}

Koopman, M. ^{[7
]}

Nagtegaal, I. ^{[8
]}

Punt, C. J. A. ^{[9
]}

van Criekinge, W. ^{[4
]}

Meijer, G. A. ^{[1
]}

Monnat, R. J. ^{[3
]}

Carvalho, B. ^{[1
]}

Grady, W. M. ^{[3
]}

机构：

[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[2] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China

[3] Univ Washington, Seattle, WA 98195 USA

[4] Univ Ghent, B-9000 Ghent, Belgium

[5] MDxHealth SA, Liege, Belgium

[6] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA

[7] Univ Med Ctr Utrecht, Nijmegen, Netherlands

[8] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands

[9] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

来源：

JOURNAL OF PATHOLOGY | 2015年 / 237卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S40 / S40

页数：1

共 50 条

[11] Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients
Paolicchi, Elisa
Vivaldi, Caterina
De Gregorio, Veronica
Crea, Francesco
Fornaro, Lorenzo
Masi, Gianluca
Loupakis, Fotios
Graziano, Francesco
Ronzoni, Monica
Ricci, Vincenzo
Falcone, Alfredo
Danesi, Romano
ONCOLOGY, 2016, 91 (05) : 283 - 288
[12] Correlation of CpG island methylation with clinical and pathologic characteristics in metastatic colorectal cancer patients
Advani, Shailesh M.
Lee, Michael Sangmin
Overman, Michael James
Fogelman, David
Kee, Bryan K.
Manuel, Shanequa D.
Davis, Jennifer
Morris, Van Karlyle
Clarke, Callisia Nathelee
Daniel, Carrie R.
Menter, David G.
Hamilton, Stanley R.
Maru, Dipen Maheshbhai
Kopetz, Scott
CANCER RESEARCH, 2015, 75
[13] CPG ISLAND METHYLATOR PHENOTYPE IS ASSOCIATED WITH THE EFFICACY OF CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER
Shimodaira, H.
Zhang, X.
Komine, K.
Takahashi, M.
Takahashi, S.
Ishioka, C.
ANNALS OF ONCOLOGY, 2014, 25
[14] Association of DNA promoter hypermethylation of decoy receptor 1 (DCR1) with poor response to irinotecan in metastatic colorectal cancer
Van Criekinge, Wim
Bosch, Linda J. W.
Trooskens, Geert
Snaebjornsson, Petur
Haan, Josien
Pelosof, Lorraine Cheryl
Koopman, Miriam
Tol, Jolien
Louwagie, Joost
Dehaspe, Luc
van Grieken, Nicole C. T.
Ylstra, Bauke
Verheul, Henk M. W.
van Engeland, Manon
Nagtegaal, Iris D.
Herman, James Gordon
Punt, Cornelis J. A.
Carvalho, Beatriz
Meijer, Gerrit A.
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
[15] EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan
Loupakis, Fotios
Cremolini, Chiara
Fioravanti, Anna
Orlandi, Paola
Salvatore, Lisa
Masi, Gianluca
Schirripa, Marta
Di Desidero, Teresa
Antoniotti, Carlotta
Canu, Bastianina
Faviana, Pinuccia
Sensi, Elisa
Lupi, Cristiana
Fontanini, Gabriella
Basolo, Fulvio
Di Paolo, Antonello
Danesi, Romano
Falcone, Alfredo
Bocci, Guido
TARGETED ONCOLOGY, 2014, 9 (03) : 205 - 214
[16] EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan
Fotios Loupakis
Chiara Cremolini
Anna Fioravanti
Paola Orlandi
Lisa Salvatore
Gianluca Masi
Marta Schirripa
Teresa Di Desidero
Carlotta Antoniotti
Bastianina Canu
Pinuccia Faviana
Elisa Sensi
Cristiana Lupi
Gabriella Fontanini
Fulvio Basolo
Antonello Di Paolo
Romano Danesi
Alfredo Falcone
Guido Bocci
Targeted Oncology, 2014, 9 : 205 - 214
[17] Cpg island hypermethylation of cell-free serum DNA indicates worse outcome in patients with bladder cancer
Bastian, Patrick J.
Ellinger, Jorg
El Kassem, Nadja
Heukamp, Lukas C.
Matthews, Swapna
Cubukluoz, Figen
Kahl, Philip
Perabo, Frank
von Rucker, Alexander
Muller, Stefan C.
JOURNAL OF UROLOGY, 2008, 179 (04): : 315 - 315
[18] Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators: diet–gene interactions and promoter CpG island hypermethylation in colorectal cancer
Stefan de Vogel
Kim A. D. Wouters
Ralph W. H. Gottschalk
Frederik J. van Schooten
Anton F. P. M. de Goeij
Adriaan P. de Bruïne
R. Alexandra Goldbohm
Piet A. van den Brandt
Manon van Engeland
Matty P. Weijenberg
Cancer Causes & Control, 2011, 22 : 1 - 12
[19] Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L
Labriet, Adrien
De Mattia, Elena
Cecchin, Erika
Levesque, Eric
Jonker, Derek
Couture, Felix
Buonadonna, Angela
D'Andrea, Mario
Villeneuve, Lyne
Toffoli, Giuseppe
Guillemette, Chantal
FRONTIERS IN PHARMACOLOGY, 2017, 8
[20] Association of FcγRIIa and FcγRIIa polymorphisms with clinical outcome in metastatic colorectal cancer patients (mCRC) treated with cetuximab and irinotecan
Bibeau, F.
Crapez, E.
Di Fiore, F.
Thezenas, S.
Sabourin, J.
Lamy, A.
Frebourg, T.
Michel, P.
Ychou, M.
Boissiere-Michot, F.
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)

← 1 2 3 4 5 →